Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of fixed-dose radioiodine therapy protocols in Graves disease (EEC region)
TCTR20220527002Recruiting
- Sponsor
- Queen Savang Vadhana Memorial Hospital
- Start
- Jan 2014
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals, Gamma Emitters → Radiopharmaceuticals
- Countries
- 1
01
Overview
Open-label trial of iodine-131 in Graves' disease (2 arms), sponsored by Queen Savang Vadhana Memorial Hospital. Primary endpoint: Treatment success rate. Started Jan 2014; status: recruiting.
02
Drugs
iodine-131
03
Conditions
Graves' disease
Beyond the preview
Go deeper on TCTR20220527002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220527002.